ECPR治疗患者心肺复苏期间心律动态对临床结局的影响:系统评价与荟萃分析
心律改善(由不可电击转为可电击)与良好神经结局概率升高相关(RR 3.12,95%CI 1.26-7.74;GRADE:低),对照为持续不可电击心律。心律恶化(由可电击转为不可电击)较持续可电击心律降低良好神经结局概率(RR 0.41,95%CI 0.21-0.80;GRADE:中)。恶化至心搏停止与良好神经恢复呈显著负相关(RR 0.20,95%CI 0.09-0.45;GRADE:中),恶化至无脉电活动未达统计学显著(RR 0.62,95%CI 0.31-1.25;GRADE:低)。
要点
- 在5183例接受ECPR的院外心脏骤停患者中,常规CPR期间心律由不可电击改善为可电击者,良好神经结局概率是持续不可电击者的3.12倍(95%CI 1.26-7.74)。
- 心律由可电击恶化为不可电击者,良好神经结局概率仅为持续可电击者的0.41倍(95%CI 0.21-0.80)。
- 恶化为心搏停止者良好神经恢复概率为持续可电击者的0.20倍(95%CI 0.09-0.45),提示ECPR前出现心搏停止可能预示复苏失败。
- 恶化为无脉电活动者未达统计学显著(RR 0.62,95%CI 0.31-1.25),尚不能据此作出明确预后判断。
适用人群与场景
- 纳入研究评估常规心肺复苏期间心律动态变化,包括心律改善(从不可电击转为可电击)或心律恶化(从可电击转为不可电击)。
诊断标准与关键阈值
- 心律改善:常规CPR期间由不可电击心律转为可电击心律。
- 心律恶化:常规CPR期间由可电击心律转为不可电击心律。
- 心律恶化进一步分为恶化为心搏停止或恶化为无脉电活动。
- 主要结局为最长随访时良好神经结局生存,次要结局为总体生存。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- ECPR候选者常规CPR期间心律由可电击恶化为心搏停止,良好神经恢复概率为持续可电击者的0.20倍(95%CI 0.09-0.45),应重新评估ECPR启动的适宜性。
- 心律恶化为不可电击心律整体上较持续可电击心律显著降低良好神经结局概率(RR 0.41,95%CI 0.21-0.80)。
研究设计与关键结果
- 心律改善组良好神经结局概率高于持续不可电击心律组:RR 3.12(95%CI 1.26-7.74;GRADE:低)。
- 心律恶化组良好神经结局概率低于持续可电击心律组:RR 0.41(95%CI 0.21-0.80;GRADE:中)。
- 恶化为心搏停止组良好神经恢复概率低于持续可电击心律组:RR 0.20(95%CI 0.09-0.45;GRADE:中)。
- 恶化为无脉电活动组与持续可电击心律组比较未达统计学显著:RR 0.62(95%CI 0.31-1.25;GRADE:低)。
- 总体生存为次要结局,原文未提供具体效应量数值。
证据类型、等级与局限
- 证据类型:系统评价与荟萃分析,纳入观察性研究。
- 原文采用GRADE分级评价证据质量,心律改善对比持续不可电击心律为低,心律恶化为中,恶化为心搏停止为中,恶化为无脉电活动为低。
- 局限:纳入研究均为观察性设计,存在混杂和偏倚风险;部分结局GRADE为低。
对床旁实践的改变
- 对ECPR候选者,不应仅记录初始心律,还应关注常规CPR期间心律动态变化。
- 心律由可电击恶化为心搏停止可能提示复苏失败和神经结局不良,临床可据此重新评估ECPR的启动。
- 恶化为无脉电活动的预后意义在本荟萃分析中未达统计学显著,不能据此单独作出放弃或启动的决策。
- 心律改善(不可电击转为可电击)与更好神经结局相关,但GRADE为低,临床解释应谨慎。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Although the initial presenting cardiac rhythm is an established prognostic factor for extracorporeal cardiopulmonary resuscitation, heart rhythm dynamics during conventional cardiopulmonary resuscitation remain poorly studied. We evaluated how the evolution of rhythm affects neurological outcomes and survival among recipients of extracorporeal cardiopulmonary resuscitation.
METHODS: We systematically searched PubMed and Embase for studies evaluating rhythm dynamics, focusing on Rhythm Improvement (from non-shockable to shockable) or Rhythm Decay (from shockable to non-shockable). The primary outcome was survival with a favorable neurological outcome at the longest follow-up; the secondary outcome was overall survival. A random-effects model analysis with the Hartung-Knapp adjustment was used.
RESULTS: Ten observational studies evaluating 5183 subjects with out-of-hospital cardiac arrest treated with extracorporeal cardiopulmonary resuscitation were included. Rhythm improvement was associated with a higher probability of a favorable neurological outcome (RR 3.12, 95% CI 1.26-7.74; GRADE: Low) compared with refractory non-shockable rhythms. Conversely, rhythm decay reduced the likelihood of a favorable neurological outcome compared with a sustained shockable rhythm (RR 0.41, 95% CI 0.21-0.80; GRADE: Moderate). Notably, decay toward asystole showed a robust negative association with good neurological recovery (RR 0.20, 95% CI 0.09-0.45; GRADE: Moderate), whereas decay toward pulseless electrical activity did not reach statistical significance (RR 0.62, 95% CI 0.31-1.25; GRADE: Low).
CONCLUSIONS: Rhythm dynamics provide valuable prognostic insights for candidates for extracorporeal cardiopulmonary resuscitation. Rhythm decay toward asystole may predict resuscitation failure and poor neurological survival, suggesting that it should prompt a critical re-evaluation of the appropriateness of extracorporeal cardiopulmonary resuscitation.
参考来源
- Resuscitation:Impact of cardiac rhythm dynamics during cardiopulmonary resuscitation on clinical outcomes in patients treated with extracorporeal cardiopulmonary resuscitation (ECPR): a systematic review and meta-analysis
- Marabotti, Cianchi, Franceschi, et al. Impact of cardiac rhythm dynamics during cardiopulmonary resuscitation on clinical outcomes in patients treated with extracorporeal cardiopulmonary resuscitation (ECPR): a systematic review and meta-analysis. Resuscitation. 2026. PMID: 42838500. doi:10.1016/j.resuscitation.2026.111348
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。